PsyPost
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
Join
My Account
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs Psilocybin

Man amputates penis with an axe after consuming psilocybin mushrooms

by Eric W. Dolan
September 29, 2024
Reading Time: 4 mins read
[Adobe Stock]

[Adobe Stock]

Share on TwitterShare on Facebook

In an unprecedented case report, doctors in Austria have documented the first known instance of psilocybin-induced penile amputation. After consuming a large quantity of magic mushrooms, a 37-year-old man suffering from depression and alcohol abuse severed his penis with an axe. Fortunately, doctors were able to reattach part of the amputated organ. The unique case is detailed in the Mega Journal of Surgery.

Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms, often referred to as “magic mushrooms.” When ingested, the compound is broken down in the body to produce psilocin, a substance that affects serotonin receptors in the brain. This can lead to a variety of mind-altering experiences, including hallucinations, changes in perception of time, and intense emotional shifts. The use of psilocybin has a long history, dating back to ancient cultures that used it for religious or spiritual purposes.

Today, psilocybin is gaining attention in medical research due to its potential therapeutic benefits. Scientists are investigating its use in treating conditions like depression, anxiety, and post-traumatic stress disorder. In particular, studies have shown promising results for psilocybin’s ability to alleviate symptoms in people with major depressive disorder, even when other treatments have failed.

In addition to its therapeutic potential, psilocybin is of interest to neuroscientists for what it reveals about the brain’s inner workings. By studying how psilocybin disrupts and alters normal brain function, researchers can gain insights into how the brain produces consciousness, processes emotions, and constructs a sense of self. These findings have the potential to improve our understanding of various mental health conditions and open new pathways for treatment.

However, while psilocybin has shown promise in clinical settings, its use outside of these controlled environments can lead to dangerous outcomes. The case described in Austria is a stark reminder that, in certain circumstances, psilocybin can provoke extreme psychological responses, particularly when taken in high doses or by individuals with a history of mental health issues.

The case report published by doctors at Hospital Feldkirch in Austria outlines the shocking details of a 37-year-old man who consumed a large dose of psilocybin and, during a severe psychotic episode, amputated his penis using an axe. The man, who had a history of depression and alcohol abuse, ingested four or five dried psilocybin mushrooms while staying alone in a secluded vacation home.

Not long after consuming the mushrooms, the man began to experience a terrifying hallucination or delusion, which led him to take an axe and sever his penis into multiple pieces. The details of the event are unclear to the patient, as he did not fully remember what had occurred.

The man reportedly tied a piece of cloth around his genital area to control the bleeding and placed the severed parts of his penis in a jar filled with snow. He then left the house, bleeding profusely, in search of help. A passerby found him in a confused state and called for emergency services. The man was transported to a nearby village and later to a hospital, arriving approximately five hours after the amputation.

Google News Preferences Add PsyPost to your preferred sources

Upon arrival, the patient was in a critical condition, having lost a significant amount of blood. He was immediately taken into surgery, where doctors worked to stabilize him and control the bleeding. His penis was contaminated with soil and snow, and parts of the organ were severely damaged. Surgeons were able to save the glans (the tip of the penis) and about two centimeters of the penile shaft, but the other sections were too damaged to be repaired.

Remarkably, the replantation was successful, despite the significant challenges posed by the extent of the injury and contamination. Despite initial difficulties, the patient’s condition improved after the surgery, although he continued to suffer from severe psychotic symptoms, including auditory hallucinations and religious delusions. He was placed under psychiatric care, and his treatment included antipsychotic medications to help control the hallucinations. His mental state gradually stabilized, and after a week, he was moved back to the urology department to continue his recovery.

In the weeks following the surgery, the patient experienced some complications. Superficial necrosis (death of skin tissue) developed on the glans of his penis, likely due to the loss of blood flow during the period of ischemia, but this healed over time. Remarkably, the patient was able to regain some erectile function within three months of the surgery, though the overall length of his penis was significantly reduced due to the damage. At his last follow-up visit, he was able to urinate normally while seated, though a minor complication called hypospadias developed, where the urethral opening is located further down the shaft than normal.

While this case is the first documented instance of psilocybin-induced self-amputation, it brings attention to a broader phenomenon of self-mutilation during psychotic episodes, particularly among individuals with underlying mental health conditions. Known as Klingsor syndrome, these rare but extreme events often involve self-inflicted injury to the genitals and can be associated with a range of psychiatric conditions, from schizophrenia to substance-induced psychosis.

Case reports are typically used by doctors and researchers to document unusual or rare medical events. They offer valuable real-world examples of how certain drugs, treatments, or conditions can manifest in unique circumstances. However, because case reports usually focus on a single patient, they do not provide the kind of broad, statistically significant data that is needed to establish definitive conclusions about a drug or condition.

In other words, while this case demonstrates that psilocybin can, in rare instances, lead to severe psychotic episodes and self-harm, it does not mean that this outcome is common or likely to happen in most people who use psilocybin. In fact, the majority of research on psilocybin has shown that the drug is relatively safe when used in controlled environments with professional supervision.

Despite their limitations, case reports play a critical role in advancing medical knowledge. They help doctors identify rare side effects, potential risks, and best practices for managing complex cases. In the case of psilocybin, reports like this one could influence future guidelines for its therapeutic use and highlight the need for careful screening of patients before administering psychedelic treatments.

The case report, “Penile Replantation after Self-Amputation Following Psilocybin-Induced Drug Psychosis,” was authored by Andreas P. Berger and and Alfred Hobisch.

RELATED

New psychology research reveals your face might determine how easily people remember your name
Addiction

A single dose of psilocybin outperforms nicotine patches for quitting smoking

April 27, 2026
New psychology research reveals your face might determine how easily people remember your name
Mental Health

Repeated doses of psilocybin show promise for treating obsessive-compulsive disorder

April 25, 2026
Neuroscience study shows how praise, criticism, and facial attractiveness interact to influence likability
Psilocybin

Brain waves predict the intensity of magic mushroom trips

April 22, 2026
Antidepressants may diminish psilocybin’s effects even after discontinuation
Depression

Psychedelic therapy and traditional antidepressants show similar results under open-label conditions

April 14, 2026
Does psilocybin really provide long-term relief from depression, as new study suggests?
Psilocybin

Psilocybin slows down human reaction times and impairs executive function during the acute phase of use

April 5, 2026
Psychedelic experiences linked to long-term improvements in psychological flexibility, study finds
Psilocybin

Can a psychedelic journey change what you value most?

April 4, 2026
The science of magic mushrooms: Fascinating findings from 7 new studies of psilocybin
Psilocybin

A new study measures the temporal distortions caused by psychedelics

March 26, 2026
New psychology research sheds light on the mystery of deja vu
Psilocybin

Study links psilocybin receptor activation to sustained structural brain changes

March 22, 2026

Follow PsyPost

The latest research, however you prefer to read it.

Daily newsletter

One email a day. The newest research, nothing else.

Google News

Get PsyPost stories in your Google News feed.

Add PsyPost to Google News
RSS feed

Use your favorite reader. We also syndicate to Apple News.

Copy RSS URL
Social media
Support independent science journalism

Ad-free reading, full archives, and weekly deep dives for members.

Become a member

Trending

  • The gender friendship gap is driven primarily by white men, not a universal difference across groups
  • General intelligence explains the link between math and music skills
  • New study reveals a striking gap between sexual pleasure and overall satisfaction in the U.S.
  • Fascinating new research suggests artificial neurodivergence could help solve the AI alignment problem
  • Childhood trauma linked to biological aging and gaze avoidance

Psychology of Selling

  • Relying on financial bonuses might actually be driving your sales team away, new research suggests
  • Why the most emotionally skilled salespeople still underperform without one key ingredient
  • Why cramped spaces sometimes make customers happier: The surprising science of “spatial captivity”
  • Seven seller skills that drive B2B sales performance, according to a Norwegian study
  • What makes customers stick with a salesperson? A study traces the path from trust to long-term commitment

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc